91416-96-5

Basic information

• Product Name: 5-iodopyrimidin-4-amine
• Synonyms: 5-iodopyrimidin-4-amine;4-Amino-5-iodopyrimidine;5-Iodo-pyrimidin-4-ylamine;4-Pyrimidinamine,5-iodo-
• CAS NO: 91416-96-5
• Molecular Formula: C₄H₄IN₃
• Molecular Weight: 221
• Product Categories: pyrimidine;Heterocycle-Pyrimidine series
• Mol File: 91416-96-5.mol
• Article Data: 6

Chemical Properties

• Melting Point: 188-189 °C
• Boiling Point: 322.7 °C at 760 mmHg
• Flash Point: 148.9 °C
• Appearance: /
• Density: 2.204 g/cm³
• Vapor Pressure: 0.000275mmHg at 25°C
• Refractive Index: 1.719
• Storage Temp.: Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
• PKA: 3.86±0.10(Predicted)
• CAS DataBase Reference: 5-iodopyrimidin-4-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-iodopyrimidin-4-amine(91416-96-5)
• EPA Substance Registry System: 5-iodopyrimidin-4-amine(91416-96-5)

Safety Data

• Hazardous Substances Data: 91416-96-5(Hazardous Substances Data)

Usage

General Description

5-iodopyrimidin-4-amine is a chemical compound with the molecular formula C4H4IN3. It is a derivative of pyrimidine and contains an iodine atom attached to the fifth carbon of the pyrimidine ring. 5-iodopyrimidin-4-amine is commonly used in organic synthesis and pharmaceutical research as a building block for the preparation of various biologically active molecules and potential drug candidates. It is also used as an intermediate in the production of agrochemicals and veterinary drugs. The presence of the iodine atom makes 5-iodopyrimidin-4-amine a useful reagent for the synthesis of diverse iodinated compounds, which have applications in medicinal chemistry and chemical biology. Overall, 5-iodopyrimidin-4-amine is an important chemical with versatile applications in the fields of pharmaceuticals, agrochemicals, and chemical research.

InChI:InChI=1/C4H4IN3/c5-3-1-7-2-8-4(3)6/h1-2H,(H2,6,7,8)

Upstream product

• 163133-86-6 pyrimidin-4-amine 

Downstream Products

• 655253-95-5 5-[(1-methyl-4-phenyl-1H-imidazol-5-yl)ethylnyl]pyrimidin-4-amine 
• 1428880-30-1 5-(3-(5-fluoro-2-methoxyphenyl)benzo[d]isoxazol-7-yl)pyrimidin-4-amine 
• 1428880-39-0 7-(4-(1H-pyrazol-1-yl)pyrimidin-5-yl)-3-(2-chlorophenyl)benzo[d]isoxazole 
• 1562399-01-2 1-(5-aminopyrimidin-4-yl)-6-(5-fluoro-2-methylphenyl)-6-methyl-4-trifluoromethylhept-1-yn-4-ol 
• 1562399-03-4 1-(4-aminopyrimidin-5-yl)-6-(5-fluoro-2-methoxyphenyl)-6-methyl-4-trifluoromethylhept-1-yn-4-ol 
• 1562399-34-1 1-(5-aminopyrimidin-4-yl)-6-(5-fluoro-2-methoxyphenyl)-6-methyl-4-trifluoromethylhept-1-yn-4-ol 
• 1562399-37-4 1-(5-aminopyrimidin-4-yl)-6-(2-methanesulfonylphenyl)-6-methyl-4-trifluoromethylhept-1-yn-4-ol 
• 1562399-39-6 1-(5-aminopyrimidin-4-yl)-6-(3-methanesulfonylphenyl)-6-methyl-4-trifluoromethylhept-1-yn-4-ol 

Relevant articles and documents

Probing the effects of pyrimidine functional group switches on acyclic fleximer analogues for antiviral activity

Due to their ability to inhibit viral DNA or RNA replication, nucleoside analogues have been used for decades as potent antiviral therapeutics. However, one of the major limitations of nucleoside analogues is the development of antiviral resistance. In that regard, flexible nucleoside analogues known as “fleximers” have garnered attention over the years due to their ability to survey different amino acids in enzyme binding sites, thus overcoming the potential development of antiviral resistance. Acyclic fleximers have previously demonstrated antiviral activity against numerous viruses including Middle East Respiratory Syndrome coronavirus (MERS-CoV), Ebola virus (EBOV), and, most recently, flaviviruses such as Dengue (DENV) and Yellow Fever Virus (YFV). Due to these interesting results, a Structure Activity Relationship (SAR) study was pursued in order to analyze the effect of the pyrimidine functional group and acyl protecting group on antiviral activity, cytotoxicity, and conformation. The results of those studies are presented herein.

Synthetic routes to a series of proximal and distal 2′-deoxy fleximers

Two series of innovative 2-deoxy nucleoside analogues have been designed where the nucleobase has been split into its imidazole and pyrimidine subunits. This structural modification serves to introduce flexibility into the nucleobase scaffold while still

SUBSTITUTED (AMINOIMINOMETHYL OR AMINOMETHYL) BENZOHETEROARYL COMPOUNDS

This invention is directed to an (aminoiminomethyl or aminomethyl) benzoheteroaryl compound of formula I which is useful for inhibiting the activity of Factor Xa by combining said compound with a composition containing Factor Xa. The present invention is also directed to compositions containing compounds of the formula I, methods for their preparation, their use, such as in inhibiting the formation of thrombin or for treating a patient suffering from, or subject to, a disease state associated with a physiologically detrimental excess amount of thrombin.